Patent Assignment
Reel/Frame 014043/0323
Change of Name
Recorded: 2003-05-14
Received: 2003-05-19
Pages: 8
Assignor
AMERICAN CYANAMID COMPANY
Executed: 2002-12-31
Assignee
WYETH HOLDINGS CORPORATION
FIVE GIRALDA FARMS, MADISON, NJ, 07940, UNITED STATES
Covered Properties
(9)
Reversal of Multidrug Resistance in Human Colon Carcinoma Cells
Application:
10/086,170 →
Substituted 3-Cyano-[1.7], [1.5], and [1.8] Naphthyridine Inhibitors of Tyrosine Kinases
Application:
10/032,587 →
Synergistic Ectoparasiticidal Methods and Compositions
Application:
09/990,600 →
N-Hydroxy-2-(Alkyl, Aryl, or Heteroaryl Sulfanyl, Sulfinyl or Sulfonyl)-3-Substituted Alkyl, Aryl or Heteroarylamides as Matrix Metalloproteinase Inhibitors
Application:
09/899,641 →
N-Hydroxy-2-(Alkyl, Aryl, or Heteroaryl Sulfanyl, Sulfinyl or Sulfonyl)-3-Substituted Alkyl, Aryl or Heteroarylamides as Matrix Metalloproteinase Inhibitors
Application:
09/898,604 →
Sustained-Release Compositions for Parenteral Administration
Application:
09/809,525 →
Method of Treating or Inhibiting Colonic Polyps
Application:
09/805,070 →
6- (Spirocyclopropyl) Penicillanic Acid 4, 4-Dioxides
Application:
09/771,440 →
Method of Inhibition of Farnesyl-Protein Transferase Using Substituted Benz (Cd) Indol-2-Imine and-Amine Derivatives
Application:
09/765,911 →